Tumor-educated T regs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche

Breast cancer is accompanied by systemic immunosuppression, which facilitates metastasis formation, but how this shapes organotropism of metastasis is poorly understood. Here, we investigate the impact of mammary tumorigenesis on regulatory T cells (T ) in distant organs and how this affects multi-o...

Full description

Saved in:
Bibliographic Details
Published in:Cell reports (Cambridge) Vol. 38; no. 9; p. 110447
Main Authors: Kos, Kevin, Aslam, Muhammad A, van de Ven, Rieneke, Wellenstein, Max D, Pieters, Wietske, van Weverwijk, Antoinette, Duits, Danique E M, van Pul, Kim, Hau, Cheei-Sing, Vrijland, Kim, Kaldenbach, Daphne, Raeven, Elisabeth A M, Quezada, Sergio A, Beyaert, Rudi, Jacobs, Heinz, de Gruijl, Tanja D, de Visser, Karin E
Format: Journal Article
Language:English
Published: United States 01.03.2022
Subjects:
ISSN:2211-1247
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Breast cancer is accompanied by systemic immunosuppression, which facilitates metastasis formation, but how this shapes organotropism of metastasis is poorly understood. Here, we investigate the impact of mammary tumorigenesis on regulatory T cells (T ) in distant organs and how this affects multi-organ metastatic disease. Using a preclinical mouse mammary tumor model that recapitulates human metastatic breast cancer, we observe systemic accumulation of activated, highly immunosuppressive T during primary tumor growth. Tumor-educated T show tissue-specific transcriptional rewiring in response to mammary tumorigenesis. This has functional consequences for organotropism of metastasis, as T depletion reduces metastasis to tumor-draining lymph nodes, but not to lungs. Mechanistically, we find that T control natural killer (NK) cell activation in lymph nodes, thereby facilitating lymph node metastasis. In line, an increased T /NK cell ratio is observed in sentinel lymph nodes of breast cancer patients compared with healthy controls. This study highlights that immune regulation of metastatic disease is highly organ dependent.
AbstractList Breast cancer is accompanied by systemic immunosuppression, which facilitates metastasis formation, but how this shapes organotropism of metastasis is poorly understood. Here, we investigate the impact of mammary tumorigenesis on regulatory T cells (T ) in distant organs and how this affects multi-organ metastatic disease. Using a preclinical mouse mammary tumor model that recapitulates human metastatic breast cancer, we observe systemic accumulation of activated, highly immunosuppressive T during primary tumor growth. Tumor-educated T show tissue-specific transcriptional rewiring in response to mammary tumorigenesis. This has functional consequences for organotropism of metastasis, as T depletion reduces metastasis to tumor-draining lymph nodes, but not to lungs. Mechanistically, we find that T control natural killer (NK) cell activation in lymph nodes, thereby facilitating lymph node metastasis. In line, an increased T /NK cell ratio is observed in sentinel lymph nodes of breast cancer patients compared with healthy controls. This study highlights that immune regulation of metastatic disease is highly organ dependent.
Author Quezada, Sergio A
Pieters, Wietske
van de Ven, Rieneke
van Weverwijk, Antoinette
Vrijland, Kim
Hau, Cheei-Sing
Kaldenbach, Daphne
de Gruijl, Tanja D
Duits, Danique E M
Kos, Kevin
de Visser, Karin E
Raeven, Elisabeth A M
Wellenstein, Max D
Aslam, Muhammad A
van Pul, Kim
Jacobs, Heinz
Beyaert, Rudi
Author_xml – sequence: 1
  givenname: Kevin
  surname: Kos
  fullname: Kos, Kevin
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 2
  givenname: Muhammad A
  surname: Aslam
  fullname: Aslam, Muhammad A
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan 60800, Pakistan
– sequence: 3
  givenname: Rieneke
  surname: van de Ven
  fullname: van de Ven, Rieneke
  organization: Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam and Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, the Netherlands
– sequence: 4
  givenname: Max D
  surname: Wellenstein
  fullname: Wellenstein, Max D
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 5
  givenname: Wietske
  surname: Pieters
  fullname: Pieters, Wietske
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands
– sequence: 6
  givenname: Antoinette
  surname: van Weverwijk
  fullname: van Weverwijk, Antoinette
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 7
  givenname: Danique E M
  surname: Duits
  fullname: Duits, Danique E M
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 8
  givenname: Kim
  surname: van Pul
  fullname: van Pul, Kim
  organization: Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam and Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, the Netherlands
– sequence: 9
  givenname: Cheei-Sing
  surname: Hau
  fullname: Hau, Cheei-Sing
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 10
  givenname: Kim
  surname: Vrijland
  fullname: Vrijland, Kim
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 11
  givenname: Daphne
  surname: Kaldenbach
  fullname: Kaldenbach, Daphne
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 12
  givenname: Elisabeth A M
  surname: Raeven
  fullname: Raeven, Elisabeth A M
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands
– sequence: 13
  givenname: Sergio A
  surname: Quezada
  fullname: Quezada, Sergio A
  organization: Cancer Immunology Unit, University College London Cancer Institute, WC1E 6DD London, UK
– sequence: 14
  givenname: Rudi
  surname: Beyaert
  fullname: Beyaert, Rudi
  organization: Center for Inflammation Research, Unit of Molecular Signal Transduction in Inflammation, VIB, 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium
– sequence: 15
  givenname: Heinz
  surname: Jacobs
  fullname: Jacobs, Heinz
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands
– sequence: 16
  givenname: Tanja D
  surname: de Gruijl
  fullname: de Gruijl, Tanja D
  organization: Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam and Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, the Netherlands
– sequence: 17
  givenname: Karin E
  surname: de Visser
  fullname: de Visser, Karin E
  email: k.d.visser@nki.nl
  organization: Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: k.d.visser@nki.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35235800$$D View this record in MEDLINE/PubMed
BookMark eNo1T9tKw0AUXESxtfYPRM4PJO4l10cpWsWiL_W5nOyetFuSzbKbCv17g5dhYBgYhpkbdukGR4zdCZ4KLoqHY6qpC-RTyaVMheBZVl6wuZRCJEJm5YwtYzzyCQUXos6u2UzlUuUV53M2bk_9EBIyJ40jGdhCoH0EE-wXwRD26JLoSdvWauhpxDjRRrAOmkCTA41OU4DmDLb3aIN1e3h_g2lS9xMbDwTdufcHcIMhcFYf6JZdtdhFWv7pgn0-P21XL8nmY_26etwkXvBqTKqSjEDE6ZE2sswQi7oSja4UN83kMsVlqzhhW2NhirwsmjovVd7WpqramtSC3f_2-lPTk9n5YHsM593_ffUNCO5ggw
ContentType Journal Article
Copyright Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1016/j.celrep.2022.110447
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2211-1247
ExternalDocumentID 35235800
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Cancer Research UK
  grantid: 22246
– fundername: Cancer Research UK
  grantid: 20764
GroupedDBID 0R~
4.4
457
53G
5VS
AAEDT
AAEDW
AAIKJ
AAKRW
AALRI
AAMRU
AAXUO
AAYWO
ABMAC
ACGFO
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AENEX
AEUPX
AEXQZ
AFPUW
AFTJW
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BAWUL
BCNDV
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EJD
FCP
FDB
FRP
GROUPED_DOAJ
GX1
IXB
KQ8
M41
M48
NPM
O-L
O9-
OK1
ROL
SSZ
ID FETCH-LOGICAL-p108t-87ed1aaa104cd274aa6981bc830db4aa4302f30eaf9a6d6576b95735f9d88f9e3
ISICitedReferencesCount 40
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000764354700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Mon Jul 21 05:45:53 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords NK cells
lymph nodes
T(regs)
metastasis
breast cancer
immunosuppression
organotropism
Language English
License Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p108t-87ed1aaa104cd274aa6981bc830db4aa4302f30eaf9a6d6576b95735f9d88f9e3
PMID 35235800
ParticipantIDs pubmed_primary_35235800
PublicationCentury 2000
PublicationDate 2022-03-01
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell reports (Cambridge)
PublicationTitleAlternate Cell Rep
PublicationYear 2022
SSID ssj0000601194
Score 2.498552
Snippet Breast cancer is accompanied by systemic immunosuppression, which facilitates metastasis formation, but how this shapes organotropism of metastasis is poorly...
SourceID pubmed
SourceType Index Database
StartPage 110447
SubjectTerms Animals
Breast Neoplasms - pathology
Carcinogenesis - pathology
Female
Humans
Killer Cells, Natural - pathology
Lymph Nodes
Lymphatic Metastasis - pathology
Mice
Title Tumor-educated T regs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche
URI https://www.ncbi.nlm.nih.gov/pubmed/35235800
Volume 38
WOSCitedRecordID wos000764354700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  databaseCode: DOA
  dateStart: 20120101
  customDbUrl:
  isFulltext: true
  eissn: 2211-1247
  dateEnd: 99991231
  titleUrlDefault: https://www.doaj.org/
  omitProxy: false
  ssIdentifier: ssj0000601194
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Li9swEBbp9sFeSt_vokNvxkHrhywdl6WlEDb0kJa9LZIlt2k3TnCcJfk9_aOdkSzH21BoD70YP4SENR_SzOibGULe5ZIbmWse57mQYKBoE0tTJrFUORdaSa4r5opNFNOpuLiQn0ajnyEW5vqqqGux3crVfxU1vANhY-jsP4i77xRewD0IHa4gdrj-neA3i2UT-4ysoE3OosZ-XUemQYqQq-EUY3QlMoSwfLQC7RBzkszrSCM_vUUaWGkbVEsxgnLu-HnTSYQe_nVgRV7tAARRvTQ2qpFLOlRxz9AbGI4i8Iw4RIUNnA4TT-6bwK7cg_M0gPN8800tFsrs3awYYwVDfbFdLgBYn38MzpSwGsw6VO08V9uOxdz5MsAM7slcY-vWvCRBhl3ik3CGBToVAyDKwWoLqkvmmx5sBN4n8X0MkwN_PMbBxofNQXKrhcMB6KF4IMz222JPVgyfbpHbSZFLObDb_XaPafOyEJbpuIOHox6Te6Gf3wwYp8jMHpD7nQVCTz1yHpKRrR-Ru74m6e4xaW_ih84o4oc6_NCb-KF7_NB5TT1-qMcP1Tva44dOJ9ThB5sBfqjDD0X8UIefJ-Tzh_ezs49xV5ojXp0w0cIeas2JUgr-rTRJkSnFJRhApUiZ0fCUpSypUmZVJRU3HIxaLfMizStphKikTZ-So3pZ2-eEVlXBKw29ZiXLKs6kYTbHgGeeppYX8gV55qfrcuXzr1yGiXz5xy-vyPEeXq_JUdts7Btyp7xu5-vmrZPfL3LVcuI
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor-educated+T+regs+drive+organ-specific+metastasis+in+breast+cancer+by+impairing+NK+cells+in+the+lymph+node+niche&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Kos%2C+Kevin&rft.au=Aslam%2C+Muhammad+A&rft.au=van+de+Ven%2C+Rieneke&rft.au=Wellenstein%2C+Max+D&rft.date=2022-03-01&rft.eissn=2211-1247&rft.volume=38&rft.issue=9&rft.spage=110447&rft_id=info:doi/10.1016%2Fj.celrep.2022.110447&rft_id=info%3Apmid%2F35235800&rft.externalDocID=35235800